Search research articles
Contact Us
Filters
Showing results (791-800 of 1,127) with videos related to
Page
of 113
Sort By:
Pediatric Cardiology
|
February 19, 2022
Native Aortic Root Thrombosis in Single-Ventricle Patients with Native-to-Neoaortic Anastomoses
Kimberly J Watkins, Jeffrey D Zampi, Ray Lowery, et al.
Environmental Science & Technology
|
December 7, 2011
Impact of dust from multiple microenvironments and diet on PentaBDE body burden
Deborah J Watkins, Michael D McClean, Alicia J Fraser, et al.
Diabetes Care
|
July 1, 1994
CD5+ B-cells at the onset of type I diabetes and in the prediabetic period
R A Smerdon, M Peakman, M J Hussain, et al.
Urology
|
February 3, 2007
Botulinum toxin B is not an effective treatment of refractory overactive bladder
G R Hirst, A J Watkins, K Guerrero, et al.
Nursing Open
|
March 9, 2026
A Multi-Method Exploration of the Support Needs of Registered Undergraduate Students of Nursing or Midwifery Transitioning Into the Workforce
Vanessa J Watkins, Tanita Botha, Angela Erwin, et al.
The British Journal of Radiology
|
April 1, 1981
left ventricular segmental wall motion-a comparison between equilibrium radionuclide angiography and contrast angiography
D N Harris, D N Taylor, B C Ogilvie, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2003
Molecular basis for fungal selectivity of novel antimitotic compounds
Thomas Lila, Thomas E Renau, Lori Wilson, et al.
Environmental Health Perspectives
|
July 1, 2011
Exposure to PBDEs in the office environment: evaluating the relationships between dust, handwipes, and serum
Deborah J Watkins, Michael D McClean, Alicia J Fraser, et al.
Nucleic Acids Research
|
July 16, 2016
The PIN domain endonuclease Utp24 cleaves pre-ribosomal RNA at two coupled sites in yeast and humans
Graeme R Wells, Franziska Weichmann, David Colvin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2014
The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study
D J Watkins, N Starling, D Cunningham, et al.
Page
of 113
Search research articles
Search
Showing results (791-800 of 1,127) with videos related to
Sort By:
Page
of 113
Pediatric Cardiology
|
February 19, 2022
Native Aortic Root Thrombosis in Single-Ventricle Patients with Native-to-Neoaortic Anastomoses
Kimberly J Watkins, Jeffrey D Zampi, Ray Lowery, et al.
Environmental Science & Technology
|
December 7, 2011
Impact of dust from multiple microenvironments and diet on PentaBDE body burden
Deborah J Watkins, Michael D McClean, Alicia J Fraser, et al.
Diabetes Care
|
July 1, 1994
CD5+ B-cells at the onset of type I diabetes and in the prediabetic period
R A Smerdon, M Peakman, M J Hussain, et al.
Urology
|
February 3, 2007
Botulinum toxin B is not an effective treatment of refractory overactive bladder
G R Hirst, A J Watkins, K Guerrero, et al.
Nursing Open
|
March 9, 2026
A Multi-Method Exploration of the Support Needs of Registered Undergraduate Students of Nursing or Midwifery Transitioning Into the Workforce
Vanessa J Watkins, Tanita Botha, Angela Erwin, et al.
The British Journal of Radiology
|
April 1, 1981
left ventricular segmental wall motion-a comparison between equilibrium radionuclide angiography and contrast angiography
D N Harris, D N Taylor, B C Ogilvie, et al.
Antimicrobial Agents and Chemotherapy
|
June 25, 2003
Molecular basis for fungal selectivity of novel antimitotic compounds
Thomas Lila, Thomas E Renau, Lori Wilson, et al.
Environmental Health Perspectives
|
July 1, 2011
Exposure to PBDEs in the office environment: evaluating the relationships between dust, handwipes, and serum
Deborah J Watkins, Michael D McClean, Alicia J Fraser, et al.
Nucleic Acids Research
|
July 16, 2016
The PIN domain endonuclease Utp24 cleaves pre-ribosomal RNA at two coupled sites in yeast and humans
Graeme R Wells, Franziska Weichmann, David Colvin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2014
The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study
D J Watkins, N Starling, D Cunningham, et al.
Page
of 113